Michael J. Bloch, MD

Conference Coverage
Conference Coverage
05/17/2023
Michael J. Bloch, MD
In this video, Michael Bloch, MD, provides a wrap-up of the session “Opportunities to Improve Metabolic Syndrome With Your Patient” during our Practical Updates in Primary Care 2023 Virtual Series,...
05/17/2023
Commentary
Commentary
01/19/2024
Evan Bloch; Michael J. Bloch, MD
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
01/19/2024
Video
Video
04/16/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, reviews and discusses a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including how the results...
04/16/2024
Commentary
Commentary
03/07/2024
Michael J. Bloch, MD; Evan Bloch
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
03/07/2024
Video
Video
04/21/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses the implications of a recently published study on the association of menstrual cycle regularity and length with cardiovascular diseases, including gaps in the...
04/21/2024
Video
Video
06/14/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses any cardiovascular benefits to the use of estrogen-free oral contraceptives in women, including a recently published study on the association of menstrual...
06/14/2024
Commentary
Commentary
10/17/2023
Michael J. Bloch, MD
In this article, Michael J. Bloch, MD, provides an analysis of the Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy Response in Hypogonadal Men trial, including the...
10/17/2023
Video
Video
02/08/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses cardiovascular disease in women, including a woman's premenopausal life and its impact on cardiovascular disease risk post-menopausally and the management of...
02/08/2024
Video
Video
06/19/2024
Michael J. Bloch, MD
In this video, Michael J. Bloch, MD, discusses the use of combined oral contraceptives, which are the most common forms of birth control used by women in the United States, oral estrogen-free progestin-only...
06/19/2024
Cardiometabolic Risk
Cardiometabolic Risk
04/08/2016
Michael J. Bloch, MD; B. Alan Bottenberg, DO
Recently, therapy to reduce PCSK9 activity has been approved for use in those with cardiovascular disease who require additional LDL-C lowering despite the use of maximally tolerated statins.
04/08/2016